The number and type of clinical applications for tissue ablation are proliferating almost as fast as the number and type of technologies and manufacturers. These versatile technologies have clinically demonstrated ability to provide therapeutic destruction of tissue, excision of tissue, formation of therapeutic lesions and other therapeutic benefits across a wide range of clinical specialties.
Over the past decade, the application of ablation technologies has been propelled by clinical evidence, indeed. The ability to precisely target malignant tissue (e.g., tumors, errant pathways in arrhythmia, fibroids, etc.) while producing minimal "collateral" tissue damage has validated many specific ablation modalities (e.g., laser, radiofrequency, microwave, cryo, etc.) for specific clinical applications. Those benefits notwithstanding, the growth of ablation technology in the medical device industry has been even further propelled by innovative manufacturers who have aligned their product development with the specific needs of clinicians and healthcare systems to produce instrumentation and equipment that facilitates the effective management of large patient caseload at reasonable cost and attractive clinical outcomes.
The future of ablation technology markets will be dictated by recent trends and the continued development of products that offer clinicians with effective tools in their armamentaria to manage growing patient populations in cost effective and clinically advantageous ways.
Below is illustrated the 2011 worldwide ablation technologies market and its forecast growth by modality type.
Source: MedMarket Diligence, LLC; Report #A145, "Ablation Technologies Worldwide Market, 2009-2019: Products, Technologies, Markets, Companies and Opportunities."